(Q34994296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

0 references

1 reference

title

The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

3 February 2020

main subject

1 reference

1 reference

1 reference

Apostolos I. Hatzitolios

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Niki Katsiki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Eleni Georgiadou

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1417-1431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19634921%20AND%20SRC:MED&resulttype=core&format=json

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00001

Use of metformin in polycystic ovary syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00001

The metabolic syndrome in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00001

Nonhypoglycemic effects of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00001

Pregnancy considerations in women with polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

1 reference

12 December 2020

Treatment of PCOS with metformin and other insulin-sensitizing agents

1 reference

12 December 2020

Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response

1 reference

12 December 2020

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

1 reference

12 December 2020

Consensus on infertility treatment related to polycystic ovary syndrome

1 reference

12 December 2020

Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors

1 reference

12 December 2020

Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome

1 reference

12 December 2020

Differentiating members of the thiazolidinedione class: a focus on safety

1 reference

12 December 2020

Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production

1 reference

12 December 2020

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

1 reference

12 December 2020

Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome

1 reference

12 December 2020

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

1 reference

12 December 2020

Thiazolidinediones: effects on insulin resistance and the cardiovascular system

1 reference

12 December 2020

Assessment and management of anovulatory infertility in polycystic ovary syndrome

1 reference

12 December 2020

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome

1 reference

12 December 2020

Diagnosis and management of polycystic ovary syndrome: a practical guide

1 reference

12 December 2020

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

12 December 2020

Insulin-sensitising agents: beyond thiazolidinediones

1 reference

12 December 2020

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

1 reference

12 December 2020

Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche

1 reference

12 December 2020

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

1 reference

12 December 2020

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

1 reference

12 December 2020

The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial

1 reference

12 December 2020

Safety profile of pioglitazone

1 reference

12 December 2020

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

1 reference

12 December 2020

Therapeutic options in the polycystic ovary syndrome

1 reference

12 December 2020

Revisit of metformin treatment in polycystic ovarian syndrome

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives

1 reference

12 December 2020

A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.

1 reference

12 December 2020

Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal

1 reference

12 December 2020

Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy

1 reference

12 December 2020

Insulin-lowering drugs in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome in adolescence

1 reference

12 December 2020

Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability

1 reference

12 December 2020

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

12 December 2020

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

1 reference

12 December 2020

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

12 December 2020

Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line

1 reference

12 December 2020

Polycystic ovarian syndrome: diagnosis and management

1 reference

12 December 2020

The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome

1 reference

12 December 2020

Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.

1 reference

12 December 2020

Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease

1 reference

12 December 2020

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone

1 reference

12 December 2020

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

1 reference

12 December 2020

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

1 reference

12 December 2020

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

12 December 2020

Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome.

1 reference

12 December 2020

Update on the management of polycystic ovary syndrome.

1 reference

12 December 2020

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

1 reference

12 December 2020

Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment

1 reference

12 December 2020

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

12 December 2020

Obesity and lifestyle management in polycystic ovary syndrome

1 reference

12 December 2020

The effect of metformin on hirsutism in polycystic ovary syndrome

1 reference

12 December 2020

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

12 December 2020

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study

1 reference

12 December 2020

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

1 reference

12 December 2020

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome

1 reference

12 December 2020

Thiazolidinediones for treatment of polycystic ovary syndrome

1 reference

12 December 2020

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

1 reference

12 December 2020

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

1 reference

12 December 2020

Metformin directly inhibits androgen production in human thecal cells

1 reference

12 December 2020

Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome

1 reference

12 December 2020

Metformin in obstetric and gynecologic practice: a review

1 reference

12 December 2020

Insulin resistance in PCOS.

1 reference

12 December 2020

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

1 reference

12 December 2020

Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries

1 reference

12 December 2020

Oral hypoglycaemic agents in 118 diabetic pregnancies.

1 reference

12 December 2020

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

1 reference

12 December 2020

Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.

1 reference

12 December 2020

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

12 December 2020

Polycystic ovary syndrome: etiology and pathogenesis

1 reference

12 December 2020

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

1 reference

12 December 2020

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

1 reference

12 December 2020

Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities

1 reference

12 December 2020

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

12 December 2020

Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome

1 reference

12 December 2020

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial

1 reference

12 December 2020

Metformin and glitazones: do they really help PCOS patients?

1 reference

12 December 2020

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

12 December 2020

The management of insulin resistance in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

12 December 2020

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

1 reference

12 December 2020

Minireview: Up-date management of non responder to clomiphene citrate in polycystic ovary syndrome.

1 reference

12 December 2020

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

1 reference

12 December 2020

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.

1 reference

12 December 2020

Insulin-sensitizing agents in polycystic ovary syndrome

1 reference

12 December 2020

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system

1 reference

12 December 2020

Polycystic ovary syndrome: a component of metabolic syndrome?

1 reference

12 December 2020

Metformin: new understandings, new uses

1 reference

12 December 2020

The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome

1 reference

12 December 2020

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

1 reference

12 December 2020

Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

1 reference

12 December 2020

Formation and early development of follicles in the polycystic ovary

1 reference

12 December 2020

Pharmacologic therapy of polycystic ovary syndrome

1 reference

12 December 2020

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review

1 reference

12 December 2020

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.

1 reference

12 December 2020

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

12 December 2020

Androgen modulation of luteinizing hormone secretion by female rat gonadotropes

1 reference

12 December 2020

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

12 December 2020

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

1 reference

12 December 2020

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

1 reference

12 December 2020

Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

1 reference

12 December 2020

Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth

1 reference

12 December 2020

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

1 reference

12 December 2020

Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome

1 reference

12 December 2020

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

1 reference

12 December 2020

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

12 December 2020

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis

1 reference

12 December 2020

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine inseminatio

1 reference

12 December 2020